Improving Clinical Translation Through Predictive In Vitro Screening Models for Oral Macrocyclic Peptides
12:00 pm - Thursday 3rd December 2026
- Compare emerging in vitro models for assessing macrocyclic peptide permeability and identify the assays that deliver the greatest predictive value for in vivo outcomes.
- Explore how formulation and screening strategies can be integrated to strengthen translational decision-making from early discovery through preclinical development.
- Learn best practices for selecting predictive screening platforms that improve candidate quality, reduce development risk, and accelerate oral peptide programmes.
